Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus.
Canonica GW, Blasi F, Carpagnano GE, Guida G, Heffler E, Paggiaro P, Allegrini C, Antonelli A, Aruanno A, Bacci E, Bagnasco D, Beghè B, Bonavia M, Bonini M, Brussino L, Caiaffa MF, Calabrese C, Camiciottoli G, Caminati M, Caruso C, Cavallini M, Chieco Bianchi F, Conte ME, Corsico AG, Cosmi L, Costantino M, Costanzo G, Crivellaro M, D'Alò S, D'Amato M, Detoraki A, Di Proietto MC, Facciolongo NC, Ferri S, Fierro V, Foschino MP, Latorre M, Lombardi C, Macchia L, Milanese M, Montagni M, Parazzini EM, Parente R, Passalacqua G, Patella V, Pelaia G, Pini L, Puggioni F, Ricciardi L, Ridolo E, Rolo J, Scichilone N, Scioscia G, Senna G, Solidoro P, Varricchi G, Vianello A, Yacoub MR, Yang B. Canonica GW, et al. Among authors: pelaia g. J Allergy Clin Immunol Pract. 2023 Dec;11(12):3629-3637. doi: 10.1016/j.jaip.2023.07.041. Epub 2023 Aug 7. J Allergy Clin Immunol Pract. 2023. PMID: 37558162 Free article. Review.
Dupilumab: a novel treatment for asthma.
Vatrella A, Fabozzi I, Calabrese C, Maselli R, Pelaia G. Vatrella A, et al. Among authors: pelaia g. J Asthma Allergy. 2014 Sep 4;7:123-30. doi: 10.2147/JAA.S52387. eCollection 2014. J Asthma Allergy. 2014. PMID: 25214796 Free PMC article. Review.
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey.
Braido F, Baiardini I, Alleri P, Bacci E, Barbetta C, Bellocchia M, Benfante A, Blasi F, Bucca C, Busceti MT, Centanni S, Colanardi MC, Contoli M, Corsico A, D'Amato M, Di Marco F, Marco D, Ferrari M, Florio G, Fois AG, Foschino Barbaro MP, Silvia G, Girbino G, Grosso A, Latorre M, Maniscalco S, Mazza F, Mereu C, Molinengo G, Ora J, Paggiaro P, Patella V, Pelaia G, Pirina P, Proietto A, Rogliani P, Santus P, Scichilone N, Simioli F, Solidoro P, Terraneo S, Zuccon U, Canonica GW. Braido F, et al. Among authors: pelaia g. Pulm Pharmacol Ther. 2017 Jun;44:83-87. doi: 10.1016/j.pupt.2017.03.013. Epub 2017 Mar 21. Pulm Pharmacol Ther. 2017. PMID: 28341462
Targeted therapy in severe asthma today: focus on immunoglobulin E.
Pelaia G, Canonica GW, Matucci A, Paolini R, Triggiani M, Paggiaro P. Pelaia G, et al. Drug Des Devel Ther. 2017 Jun 29;11:1979-1987. doi: 10.2147/DDDT.S130743. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28721017 Free PMC article. Review.
The Severe Asthma Network in Italy: Findings and Perspectives.
Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G, Senna G, Canonica GW; SANI Network. Heffler E, et al. Among authors: pelaia g. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1462-1468. doi: 10.1016/j.jaip.2018.10.016. Epub 2018 Oct 25. J Allergy Clin Immunol Pract. 2019. PMID: 30368004 Free article.
Early management of COPD: where are we now and where do we go from here? A Delphi consensus project.
Di Marco F, Balbo P, de Blasio F, Cardaci V, Crimi N, Girbino G, Pelaia G, Pirina P, Roversi P, Santus P, Scichilone N, Vatrella A, Pasqualetti P, Carone M. Di Marco F, et al. Among authors: pelaia g. Int J Chron Obstruct Pulmon Dis. 2019 Feb 4;14:353-360. doi: 10.2147/COPD.S176662. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 30787604 Free PMC article. Review.
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes.
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Ricci A, Cresti A, Santus P, Olivieri C, Perrella A, Rogliani P, Paggiaro P; Omalizumab Italian Study Group. Sposato B, et al. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1643-1646. doi: 10.1016/j.jaip.2019.03.006. Epub 2019 Mar 19. J Allergy Clin Immunol Pract. 2019. PMID: 30898690 No abstract available.
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry.
Canonica GW, Colombo GL, Bruno GM, Di Matteo S, Martinotti C, Blasi F, Bucca C, Crimi N, Paggiaro P, Pelaia G, Passalaqua G, Senna G, Heffler E; SANI Network. Canonica GW, et al. Among authors: pelaia g. World Allergy Organ J. 2019 Jan 26;12(1):100007. doi: 10.1016/j.waojou.2018.12.001. eCollection 2019. World Allergy Organ J. 2019. PMID: 30937132 Free PMC article.
196 results